Top Trends Driving Innovation and Change in the Pelvic Inflammatory Disease (PID) Treatment Market: Lee Health Domain Introduces V-Ferin For Vaginal Health
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Pelvic Inflammatory Disease (PID) Treatment Market, and What Factors Will Drive It?
The pelvic inflammatory disease (pid) treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the growing adoption of telemedicine, rising incidence of sexually transmitted infections, increasing cases of sexually transmitted infections (STIs), rising awareness of pelvic inflammatory disease, and increasing healthcare expenditure.
In the coming years, the market for treatment of pelvic inflammatory disease (pid) is anticipated to experience robust expansion. It is projected to reach$5.84 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. This predicted growth during the forecast period can be ascribed to factors such as the escalating incidence of sexually transmitted infections, augmented understanding of female reproductive health, heightened awareness of pelvic inflammatory disease, increased utilization of telehealth facilities, and the mounting occurrence of sexually transmitted infections (STIs). Significant trends during this period involve state-of-the-art treatment products for pelvic inflammatory disease, advancements in diagnostic methodologies, breakthroughs such as customized treatment, highly developed imaging techniques, and technological progression.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21251&type=smp
What External and Internal Drivers Are Contributing to the Growth of thePelvic Inflammatory Disease (PID) Treatment Market?
The rise in sexually transmitted infection cases is anticipated to boost expansion in the pelvic inflammatory disease (PID) treatment market. These infections, which can be transmitted through vaginal, anal, or oral sex, are caused by bacteria, viruses, or parasites. The rising prevalence of these infections is due to factors including risky sexual behaviors, unprotected sex, lack of knowledge, and delay in testing and treatments. PJ treatment, which involves the use of antibiotics to kill the bacteria causing infection, is beneficial for managing sexually transmitted infections. It works to prevent complications like chronic pelvic pain and infertility, and reduces the chances of repeated infections. As per a report provided by the UK Health Security Agency (UKHSA), a government agency based in the UK, in 2023 England reported a 51% increase in new human immunodeficiency virus (HIV) diagnoses with 6,008 cases, compared to 3,975 diagnoses in 2022. Hence, the surge in sexually transmitted infections is a major contributor to the growth of the pelvic inflammatory disease (PID) treatment market.
What Segment Types Define the Pelvic Inflammatory Disease (PID) Treatment Market Structure?
The pelvic inflammatory disease (pid) treatmentmarket covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy; Surgery; Pain Management; Hormonal Therapy
2) By Route Of Administration: Oral; Intravenous; Intramuscular
3) By End User: Hospitals; Clinics; Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics; Combination Antibiotic Therapy; Oral Antibiotics; Intravenous Antibiotics
2) By Surgery: Laparoscopy; Hysterectomy; Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioid Analgesics; Acetaminophen; Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills; Hormonal Intrauterine Device (IUD); Progesterone Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21251&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Pelvic Inflammatory Disease (PID) Treatment Market?
North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (PID) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Pelvic Inflammatory Disease (PID) Treatment Market?
Key market players in the pelvic inflammatory disease (PID) treatment sector are evolving their strategies, focusing on creating innovative formulas such as probiotic supplements. These supplements are aimed at improving the treatment efficiency, reestablishing the balance of vaginal microbiota, and decreasing the frequency of infection recurrences in patients afflicted with PID. Probiotic supplements are products dense with beneficial live bacteria or yeasts which help in maintaining or reinstating a healthy equilibrium of gut and vaginal microbiota. For example, in November 2024, Lee Health Domain, a pharmaceutical corporation based in India, introduced V-Ferin, a probiotic supplement purposed for enhancing vaginal health. V-Ferin, which is comprised of Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, is designed to renew the natural microbiome, and deter common vaginal infections such as bacterial vaginosis and yeast infections. Considering that about 25-30% of women are susceptible to these diseases – which could potentially lead to PID if not addressed – V-Ferin provides a unique solution to enhance health and avoid complications.
View the full report here:
What Is the Definition of the Pelvic Inflammatory Disease (PID) Treatment Market?
Pelvic inflammatory disease (PID) treatment refers to the medical management of infections affecting the female reproductive organs, typically caused by sexually transmitted bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae. Treatment aims to eliminate the infection, alleviate symptoms, and prevent complications such as infertility, chronic pelvic pain, and ectopic pregnancy.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21251
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
